About Gentium Srl (OTCMKTS:GENTY)
Gentium SpA is a biopharmaceutical company focused on the development and manufacture of its product candidate, defibrotide, an investigational drug based on a mixture of single-stranded and double-stranded deoxyribonucleic acid (DNA) extracted from pig intestines. The Company's development of defibrotide has been focused on the treatment and prevention of a disease called hepatic veno-occlusive disease ( VOD), a condition that occurs when veins in the liver are blocked as a result of cancer treatments, such as chemotherapy or radiation, that are administered prior to stem cell transplantation. In February 2014, Jazz Pharmaceuticals PLC acquired the 98% interest in Gentium SpA (Gentium).
Industry, Sector and Symbol
Trailing P/E Ratio107.884615384615
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Gentium Srl (OTCMKTS:GENTY) Frequently Asked Questions
What is Gentium Srl's stock symbol?
Gentium Srl trades on the OTCMKTS under the ticker symbol "GENTY."
Who are some of Gentium Srl's key competitors?
Some companies that are related to Gentium Srl include CONMED (CNMD), Intrexon (XON), Spectranetics (SPNC), Radius Health (RDUS), Arena Pharmaceuticals (ARNA), Mallinckrodt (MNK), ImmunoGen (IMGN), Mazor Robotics (MZOR), Iovance Biotherapeutics (IOVA), Tivity Health (TVTY), Sirtex Medical (SRX), Editas Medicine (EDIT), Examworks Group (EXAM), Accelerate Diagnostics (AXDX), Atara Biotherapeutics (ATRA), Heron Therapeutics (HRTX), Clinigen Group (CLIN) and TherapeuticsMD (TXMD).
Who are Gentium Srl's key executives?
Gentium Srl's management team includes the folowing people:
- Khalid Islam Ph.D., Chairman of the Board, Chief Executive Officer, Interim Scientific Director (Age 61)
- Salvatore Calabrese, Chief Financial Officer, Chief Operating Officer (Age 44)
- Carin Heringa, Senior Vice President, Scientific Director (Age 52)
- Marco Maria Brughera, Director (Age 60)
- Laura Ferro Ph.D., Director (Age 62)
- Gigliola Bertoglio CPA, Independent Director (Age 79)
- Bobby W. Sandage Jr., Ph.D., Independent Director (Age 63)
- Elmar J. Schnee, Independent Director (Age 57)
How do I buy Gentium Srl stock?
Shares of Gentium Srl can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Gentium Srl's stock price today?
One share of Gentium Srl stock can currently be purchased for approximately $56.10.
How big of a company is Gentium Srl?
Gentium Srl has a market capitalization of $872.64 million.
How can I contact Gentium Srl?
Gentium Srl's mailing address is Piazza XX Settembre, 2, VILLA GUARDIA, 22079, Italy. The biopharmaceutical company can be reached via phone at +39-31-5373200.
MarketBeat Community Rating for Gentium Srl (GENTY)MarketBeat's community ratings are surveys of what our community members think about Gentium Srl and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Gentium Srl (OTCMKTS:GENTY) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Gentium Srl (OTCMKTS:GENTY) Earnings History and Estimates Chart
Gentium Srl (OTCMKTS GENTY) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|10/31/2013||$0.20||$0.22||$15.75 million||$16.19 million||View||Listen|
|8/13/2013||Q2 2013||$0.02||$0.16||$13.49 million||$13.62 million||View||N/A|
|5/14/2013||Q1 2013||($0.08)||$0.06||$8.82 million||$10.51 million||View||N/A|
Gentium Srl (OTCMKTS:GENTY) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Gentium Srl (OTCMKTS:GENTY)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Gentium Srl (OTCMKTS GENTY)
No insider trades for this company have been tracked by MarketBeat.com
Gentium Srl (OTCMKTS GENTY) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Gentium Srl (OTCMKTS:GENTY) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Gentium Srl (OTCMKTS GENTY) Stock Chart for Saturday, February, 17, 2018